Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter

Oncogene

Volumn 12, Issue 1, 1996, Pages 111-118

  Rochefort, Pascale ^a   Caillou, Bernard ^a   Michiels, Francine Marie ^a   Ledent, Catherine ^b   Talbot, Monique ^a   Schlumberger, Martin ^a   Lavelle, François ^c   Monier, Roger ^a   Feunteun, Jean ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c SANOFI   (France)

Author keywords

Activated ras; Papillary thyroid carcinoma; Thyroid dysgenesis; Transgenic mice

Indexed keywords

THYROGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GOITER; GROWTH RETARDATION; LUNG CARCINOMA; MALE; MORPHOGENESIS; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; THYMUS HYPERPLASIA; THYROID CARCINOMA; THYROID DISEASE; THYROID HYPERPLASIA; TRANSGENE;

EID: 0030061770     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adams JM and Cory S. (1991). Science, 254, 1161-1167.
2. Andres AC, Bchini O, Schubaur B, Dolder B, LeMeur M and Gerlinger P. (1991). Oncogene, 6, 771-779.
3. Avvedimento VE, Musti AM, Ueffing M, Obici S, Gallo A, Sanchez M, Debrasi D and Gottesman ME. (1991). Genes Dev. 5, 22-28.
4. Biancifiori C. (1979). Pathology of tumors in animal laboratory animals, (ed) Turusov VS. Lyon: IARC, pp 451-468.
5. Bohinski RJ, Di Lauro R and Whitsett JA. (1994). Mol. Cell. Biol., 14, 5671-5681.
6. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G and Della Porta G. (1989). Oncogene, 4, 1457-1462.
7. Bos JL. (1989). Cancer Research, 49, 4682-4689.
8. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ. (1979). Biochemistry, 18, 5294-5297.
9. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL and Palmiter RD. (1989). Cell, 59, 1145-1156.
10. Christophe D, Gerard C, Juvenal G, Bacolla A, Teugels E, Ledent C, Christophe-Hobertus C, Dumont JE and Vassart G. (1994). Mol. Cell. Endocrinol., 64, 5-18.
11. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N and Dove W. (1993). Cell, 75, 631-639.
12. Fowlis DJ and Balmain A. (1993). Eur. J. Cancer, 29, 638-645.
13. Francis-Lang H, Zannini M, de Felice M, Berlingieri MT, Fusco A and Di Lauro R. (1992). Mol. Cell. Biol., 12, 5793-5800.
14. Gallo A, Benusiglio E, Bonapace IM, Feliciello A, Cassano S, Garbi C, Musti AM, Gottesman ME and Avvedimento EV. (1992). Genes Dev., 6, 1621-1630.
15. Guazzi S, Price M, de Felice M, Damante G, Mattei MG and Di Lauro R. (1990). EMBO J., 9, 3631-3639.
16. Guazzi S, Lonigro R, Pintonello L, Boncinelli E, Di Lauro R and Mavilio F. (1994). EMBO J., 13, 3339-3347.
17. Hogan BLM, Costantini F and Lacy E. (1986). Manipulating the mouse embryo: a laboratory manual, New York: Cold Spring Harbor Laboratory.
18. Karga H, Lee JK, Vickery AL, Thor A, Gaz RD and Jameson JL. (1991). J. Clin. Endocrinol. Metabol., 73, 832-836.
19. Ledent C, Parmentier M and Vassart G. (1990). Proc. Natl. Acad. Sci. USA, 87, 6176-6180.
20. Ledent C, Dumont JE, Vassart G and Parmentier M. (1991). Endocrinology, 129, 1391-1401.
21. Ledent C, Dumont JE, Vassart G and Parmentier M. (1992). EMBO J., 11, 537-542.
22. Lemoine NR, Mayall E, Wyllie FS, Williams ED, Thurston V and Wynford-Thomas D. (1988). Oncogene, 3, 541-544.
23. Lemoine NR, Mayall ES, Wyllie FS, Williams BD, Goyns M, Stringer B and Wynford-Thomas D. (1989). Oncogene, 4, 159-164
24. Lemoine NR, Staddon S, Bond J, Wyllie FS, Shaw JJ and Wynford-Thomas D. (1990). Oncogene, 5, 1833-1837
25. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD and Buchberg AM. (1995). Cell, 81, 957-966.
26. Michiels FM, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury M-T, Schlumberger M, Mercken L, Monier R and Feunteun J. (1994). Proc. Natl. Acad. Sci. USA, 91, 10488-10492.
27. Namba H, Gutman RA, Matsuo K, Alvarez A and Fagin JA. (1990). J. Clin. Endocrinol. Metabol., 71, 223-229.
28. Palmiter RD and Brinster RL. (1986). Annu. Rev. Genet., 20, 465-499.
29. Said S, Schlumberger M and Suarez HG. (1994). J. Endocrinol. Invest., 17, 371-379.
30. Santelli G, De Franciscis V, Portella G, Chiappetta G, D'Alessio A, Califano D, Rosati R, Mineo A, Monaco C, Manzo G, Pozzi L and Vecchio G. (1993). Cancer Res., 53, 5523-5527
31. Santoro M, Carlomagno F, Hay ID, Hermann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger Bergber N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB and Fusco A. (1992). J. Clin. Invest., 89, 1517-1522.
32. Schlumberger M, Tubiana M, de Valthaire F, Hill C, Gardet P, Travagli JP, Fragu P, Lumbroso JD, Caillou B and Parmentier C. (1986). J. Clin. Endocrinol. Metab., 63, 960-967.
33. Shi Y, Zou M, Schmidt H, Juhasz F, Stensky V, Robb D and Farid NR. (1991). Cancer Res., 51, 2690-2693.
34. Su L-K, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA and Dove WF. (1992). Science, 256, 668-670.
35. Suarez HG, du Villard JA, Severino M, Calliou B, Schlumberger M, Tubiana M, Parmentier C and Monier R. (1990). Oncogene, 5, 565-570.
36. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C and Monier R. (1991). Oncogene, 6, 677-679.
37. Tremblay PJ, Pothier F, Hoang T, Tremblay G, Brownstein S, Liszauer A and Jolicoeur P. (1994). Mol. Cell. Biol., 9, 854-859.
38. Whitten WK. (1971). Adv. Biosc., 6, 129-141.
39. Wright PA, Williams ED, Lemoine NR and Wynford-Thomas D. (1991). Oncogene, 6, 471-473.
40. Yukawa K, Kikutani H, Inomoto T, Uchira M, Bin SH, Akagi K, Yamamura KI and Kishimotao T. (1989). J. Exp. Med., 170, 711-726.